Meanwhile, miR-223-3p mediates CXCR4 16 in papillary thyroid carcinoma, silences EGR1 and RHOB15 in non-small-cell lung cancer, and epigenetically inhibits PLEKHO1 expression31 in gastric cancer. Here, CXCR4 is linked to thyroid gland papillary carcinoma.